Cerus Corporation CERS
NASDAQ · United States · Health Technology
$2.28-0.04 (-1.72%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.01 | -0.01 | +25.0% | $63.30M | +0.6% | -25.1%$2.87→$2.15 |
| Q1 2026 | 2026-04-30 | -0.01 | -0.03 | +66.7% | — | — | +41.7%$1.92→$2.72 |
| Q4 2025 | 2026-03-02 | -0.01 | 0.00 | — | — | — | -16.8%$2.56→$2.13 |
| Q3 2025 | 2025-11-06 | 0.00 | -0.02 | +100.0% | — | — | +17.9%$1.45→$1.71 |
| Q4 2024 | 2025-02-20 | -0.01 | -0.01 | 0.0% | — | — | — |
| Q4 2023 | 2024-03-05 | -0.01 | -0.02 | +50.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.